NCT04678648 2026-03-18
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
Phase 1 Recruiting
RasCal Therapeutics, Inc.
M.D. Anderson Cancer Center
West German Study Group
University of Eastern Finland
Institut du Cancer de Montpellier - Val d'Aurelle
AstraZeneca